The analysis of R-6 and the comparative analysis of R-6 variations converged to suggest that the TNF signaling pathway is the key mechanism involved in the action of R-6 on DN among patients with DN presenting with different clinical phenotypes. This evidence concerns the gene TNF and liver dysplastic nodule.